Ventilator Firms Across Europe Ramp Up Production To Meet ‘Unprecedented’ Demand

Production of ventilators is up by tens of thousands of units across Europe, but the supply chain is likely to come under strain with further expansion. 

Woman_Ventilator_Hospital
• Source: Shutterstock

As Europe becomes the epicenter of the COVID-19 outbreak, authorities are becoming increasingly concerned about a potential lack of ventilators, which are a key treatment for patients struggling to breathe as a result of the respiratory coronavirus. According to the World Health Organization, around 14% of COVID-19 patients will require hospitalization and oxygen support, and 5% will need to be admitted to an intensive care unit.

Italy, which has been hardest hit by the outbreak, has tendered for 5,000 ventilators and other desperately needed medical equipment. Medtronic PLC was one of the companies to respond....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.